BOLT / Bolt Biotherapeutics, Inc. - Net Long/Short Value

Bolt Biotherapeutics, Inc.
US ˙ NasdaqCM ˙ US0977021049

BOLT / Bolt Biotherapeutics, Inc. - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
Morgan Stanley
Nan Fung Group Holdings Ltd
Susquehanna International Group, Llp
T3 Companies, LLC
Board of Trustees of The Leland Stanford Junior University
Pfizer Inc
Vanguard Fiduciary Trust Co
Jpmorgan Chase & Co
Sofinnova Investments, Inc.
Tower Research Capital LLC (TRC)
Barclays Plc
Lynx1 Capital Management LP
Vanguard Capital Management Llc
Citadel Advisors Llc
SBI Securities Co., Ltd.
Danske Bank A/s
Vanguard Global Advisers, LLC
UBS Group AG
Geode Capital Management, Llc
Nano Cap New Millennium Growth Fund L P
Vanguard Group Inc
Vivo Capital, LLC
BlackRock, Inc.
Renaissance Technologies Llc
Shay Capital LLC
Pivotal bioVenture Partners Investment Advisor LLC
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista